Scholars@Duke

• Research
• 

  Selected Grants

  • Manipulating normal estrogen physiology as a therapeutic approach in cancer awarded by National Institutes of Health 2023 - 2028
  • Cancer cell intrinsic and extrinsic actions of steroid hormones in breast tumors awarded by Department of Defense 2018 - 2023
  • Evaluation of estrogen receptor as a therapeutic target in melanoma, lung and colorectal cancer models awarded by Zentalis Pharmaceuticals 2020 - 2022
  • Pharmacological targeting of estrogen receptor to enhance melanoma immunity awarded by The Melanoma Research Foundation 2019 - 2021
  • Evaluation of novel CDK4/6/9 inhibitors in triple negative breast cancer awarded by SPV Therapeutics, Inc 2020

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.